Next-generation Sequencing Services Market worth $8.77 billion by 2030
The report "Next-generation Sequencing Services Market by Type (Sequencing, Presequencing, Bioinformatics, Platform services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma Biotech) - Forecast to 2030" is projected to grow from USD 3.80 billion in 2025 and to reach 8.77 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 18.2% during the forecast period.
Browse 400 market data Tables and 40 Figures spread through 400 Pages and in-depth TOC on "Next-generation Sequencing Services Market by Type (Sequencing, Presequencing, Bioinformatics, Platform services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma Biotech) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/ngs-services-market-194102241.html
Multiple factors are driving growth in the global next-generation sequencing services market. Rising cancer burden and expanding rare-disease programs are increasing demand for fast, report-ready sequencing in routine and translational settings. Sequencing has become far more affordable over time, making larger studies and higher clinical volumes easier to justify. At the same time, population genomics and national genomics initiatives are expanding across regions, creating steady, repeatable project flows for outsourced sequencing and downstream analysis.
The sequencing segment accounted for the dominant share in 2024.
By service type, the next-generation sequencing services market is divided into sequencing services, pre-sequencing services, bioinformatics services, and NGS platform services. In 2024, sequencing-led services remained at the forefront; this dominance is largely volume-driven, with service providers running high-throughput projects for oncology, rare disease, reproductive health, and surveillance.
The diagnostics application segment is estimated to be the largest and register the highest CAGR from 2025 to 2030 in the NGS services market.
By application, the next-generation sequencing services market is divided into diagnostics, drug discovery and development, agriculture & animal research, and other applications. The diagnostics application segment dominated the market in 204, reflecting heavy testing demand from oncology, hereditary disease, and infectious disease workflows. Growth is being driven by the routine use of tumor profiling and comprehensive genomic profiling (CGP), as well as the steady rise in companion diagnostics tied to targeted therapies.
Asia Pacific is likely to be the fastest growing region in the global NGS services market during the forecast period.
By country, the Asia Pacific next-generation sequencing services market is divided into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China is emerging as the key growth engine, driven by high clinical testing volumes, a robust network of large hospitals and reference labs, and the rapid scale-up of outsourced sequencing for oncology, rare diseases, and infectious disease surveillance. Growth is also aided by the expansion of biopharma R&D and trial genomics, which drives repeat demand for sequencing and analysis.
Prominent players operating in the NGS services market include Illumina, Inc. (US), Thermo Fisher Scientific (US), and Eurofins Scientific (Luxembourg), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Next-Generation Sequencing (NGS) Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
